One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-149600
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 11 |
Affiliation: Institut Polytechnique de Paris, Institut Gustave Roussy, Inserm, University of Paris-Saclay, Hospital San Pedro de Alcántara, Nantes Université, Centre d'Investigation Clinique de Nantes, Centre Hospitalier Universitaire de Nantes, Klinikum Chemnitz, Amphia Ziekenhuis, University of Lübeck, Kiel University, University Hospital Schleswig-Holstein, Instituto Português de Oncologia Francisco Gentil, LMU Klinikum, Ludwig-Maximilians-Universität München, Centre Hospitalier Annecy Genevois, Spaarne Ziekenhuis, The Maria Sklodowska-Curie National Research Institute of Oncology, Klinikum St. Marien Amberg, CHU Dinant Godinne UCL Namur, Centre Hospitalier Universitaire de Nancy, Hôpital Lyon Sud, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, Délégation Paris 7, Université Paris Cité, Université de Caen Normandie, Centre Hospitalier Universitaire de Caen, Vall d'Hebron Hospital Universitari, Gdańsk Medical University, University Medical Center Groningen, University of GroningenRituximab-Lenalidomide(R2) Maintenance Is Superior to Rituximab Maintenance after First Line Immunochemotherapy in Mantle Cell Lymphoma: Results of the MCL R2 Elderly Clinical Trial
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
